Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesFeb 21, 2013View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventFeb 21, 2013View HTMLDownload DOCDownload PDFDownload XLS
5Annual filing director officer or owner of more than ten percent.Feb 15, 2013View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2013View HTMLDownload DOCDownload PDFDownload XLS
5Annual filing director officer or owner of more than ten percent.Feb 14, 2013View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 14, 2013View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2013View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2013View HTMLDownload DOCDownload PDFDownload XLS
5Annual filing director officer or owner of more than ten percent.Feb 14, 2013View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 14, 2013View HTMLDownload DOCDownload PDF
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsFeb 13, 2013View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 13, 2013View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 13, 2013View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 13, 2013View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 12, 2013View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Feb 11, 2013View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Feb 11, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 5, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 24, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 24, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 24, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 23, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 23, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 23, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 8, 2013View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-150      151-153

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information